secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001193125-23-000889
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx appoints Ricci S. Whitlow as COO effective January 3, 2023
-----------------------------------------------------------------

- Whitlow most recently President, Clinical Supply Services at Catalent; 30+ years MedTech experience.
- Compensation: base salary $540k, target bonus 50% of base, sign-on $50k, RSU grant of 300% of base salary.
- Will lead manufacturing, supply chain, procurement, quality, and regulatory functions.
- Severance benefits: 1.25x base+bonus for no-cause termination, 1.5x upon change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523000889/0001193125-23-000889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523000889/d407336d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-000889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer